Primary hyperparathyrodism: Postoperative long-term evolution;Hiperparatirodismo primario: Evolucion postoperatoria a largo plazo

Medicina

Volumn 70, Issue 5, 2010, Pages 408-414

  Spivacow, Francisco R ^a   Martinez, Carolina ^a   Polonsky, Ana ^a  

^a UNIVERSIDAD DEL SALVADOR   (Argentina)

Author keywords

Long term postoperative evaluation; Primary hyperparathyroidism

Indexed keywords

CALCIUM; CALCIUM ION; PARATHYROID HORMONE; PHOSPHORUS; BIOLOGICAL MARKER;

ADULT; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION; HUMAN; HYPERCALCIURIA; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; OSTEOPENIA; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE CARE; PRIMARY HYPERPARATHYROIDISM; TREATMENT OUTCOME; AGED; BLOOD; BONE REMODELING; DENSITOMETRY; METABOLISM; MIDDLE AGED; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; TIME;

AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; DENSITOMETRY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; POSTOPERATIVE PERIOD; TIME FACTORS; TREATMENT OUTCOME;

EID: 79957968329     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bilezikian JP, Silverberg HJ. Asymptomatic primary hyperparathyroidism. N Engl J Med 2004; 350: 1746-51.
2. Mautalen CA, Gallo Morando C, Torres Agüero M, Barcat JA, Arata RO. Molins M. Tratamiento quirúrgico del hiperparatiroidismo. Medicina (Buenos Aires) 1972; 32: 150-8.
3. Boonstra C. Jackson C. Serum calcium survey for hyperparathyroidism: Results in 50.000 clinic patients. Am J Clin Pathol 1971; 55: 523-8.
4. AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 2005; 11: 49-54.
5. Silverberg SJ, Gartenberg F, Jacobs TP, et al. Increased bone mineral density after parathyroidectomy in primary Hyperparathyroidism. J Clin Endocrinol Metab 1995; 80: 729-34.
6. Consensus Development Conference Statement on Diagnosis and Management of Asyntomatic Primary Hyperparathyrodism. J Bone Miner Res 1991; 6: S9-S13.
7. Bilezikian JP, Potts JT, Jr Fuleihan GE, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 2002; 87: 5353-61.
8. Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomaticprimaryhyperparathyroid-asymptomatic primary hyperparathyroidism: Summary Statement from the Third International Workshop. J Clin Endocrinol Metab 2009; 94: 335-39.
9. Sánchez A, Ercolano M, Frigeri A, et al. Consenso de la Federación Argentina de Sociedades de Endocrinología (FASEN) sobre Hiperparatiroidismo Primario. Revista Argentina de Endocrinología y Metabolismo 2006; 43: 160-73.
10. Orwoll ES, Oviatt SK, Biddle JA. Precision of Dual-Energy X-Ray 12. Absorptiometry: Development of quality control rules and their application in longitudinal studies. J Bone Miner Res 1993; 8: 693-9.
11. Martin P, Bergmann P, Gillet C. Partially reversible osteopenia after surgery for primary hyperparathyroidism. Arch Intern Med 1986; 146: 689-91.
12. Richardson ML, Pozzi-Mucelli RS, Kanter AS, Kolb FO, Ettinger B, Genant HK. Bone mineral changes in primary hyperparathyroidism. Skel Radiol 1986; 15: 85-95.
13. Parisien M, Dempster DW, Shane E, Bilezikian J. Histomorphometric analysis of bone in primary hyperparathyroidism. In The Parathyroids. (Edited by JP Bilezikian. MA Levine and R Marcus) New York: Raven Press Ltd, 1994, pp 493-503.
14. Wishart J, Horowitz M, Need A, Nordin BE. Relationship between forearm and vertebral mineral density in postmenopausal women with primary hyperparathyroidism Arch Intern Med 1990; 150: 1329-31.
15. Wilson RJ, Rao S, Ellis B, Kleerekoper M, Parfitt AM. Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 1988; 109: 95962.
16. Vestergaard P, Mollerup CL, Frakjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 2000; 321: 598-602
17. Rao DS, Phillips ER, Divine GW, Talpos GB. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic prymary hyperparathyroidism. J Clin Endocrinol Metab 2004; 80: 5415-22.
18. Bollerslev J, Jansson S, Mollerup CL, et al. Medical observation compared to Parathyroidectomy for asymptomatic primary hyperparathyroidism: a prospective. Randomized trial. J Clin Endocrinol Metab 2007; 92: 1687-92.
19. Christiansen P, Steiniche T, Brixen K, et al. Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients. A three year followup study. Bone 1999; 25: 589-95.
20. Ambrogini E, Cetani F, Cianferotti L, et al. Surgery or Surveillance for Mild Asynptomatic Primary Hyperparathyroidism: A Prospective. Randomized Clinical Trial. J Clin Endocrinol Metab 2007; 92: 3114-21.
21. Alledorf J, Kim I, Chabot J, DiGiorgi M, Spanknebel K, LoGerfo P. The impact of Sestamibi scanning on the outcome of parathyroid surgery. J Clin Endocrinol Metab 2003; 88: 3015-8.
22. Walgenbach S, Hommel G, Junginger T. Outcome after surgery for primary hyperparathyroidism: ten year prospective follow-up study. World J Surg 2004; 24: 564-9.
23. Silverberg SJ, Shane E, Jacob TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999; 341: 1249-55.
24. Corbetta S, Baccarelli A, Aroldi A, et al. Risk factors associated to kidney stones in primary hyperparathyroidism. J Endocrinol Invest 2005; 28: 122-8.
25. Silverberg SJ, Shane E, Jacobs TP, et al. Neprholithiasis and bone involvement in primary hyperparathyroidism. Am J Med 1990; 89: 327-34.
26. Pak CY, Nicar MJ, Peterson R, et al. A lack of unique pathophysiologic background for neprhrolithiasis of primary hyperparathyroidism. J Clin Endocrinol Metab 1981; 53: 536-42.
27. Parks JH, Coe FL, Evan AP, Worcester Evan, Elaine M. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int 2009; 103: 670-8.
28. Parfitt AM. Accelerated cortical bone loss; primary and secondary hyperparathyroidism. In: Uhthoff HK. Stahl E. eds. Current concepts of bone fragility. Berlin: Springer-Verlag,1986: 279-85.
29. Silverberg SJ, Shane E, de la Cruz L, et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 1989; 4: 283-91.
30. Reeve J, Meunier PJ, Parsons JA, et al. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. BMJ 1980; 280: 1340-4.
31. Slovik DM, Rosenthal DI, Doppelt SH, et al. Restoration of spinal bone in osteoporosis men by treatment with human parathyroid hormone (1-34) and 1.25-dihydroxyvitamin D. J Bone Miner Res 1986; 1: 377-81.
32. Delling G. Bone morphology in primary hyperparathyrodism. A qualitative and quantitative study of 391 cases. Appl pathol 1987; 55: 147-59.
33. Jansson S, Morgan E. Biochemical effects from treatment with bisphosphonate and surgery in patients with primary hyperparathyroidism. World J Surg 2004; 28: 1293-7.
34. Clemens MR, Davies M, Fraser DR, Lumb GA, Mawer EB, Adams PH. Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Clin Sci 1987; 73: 659-64.
35. Tassone F, Gianotti L, Emmolo I, Ghio M, Borretta G. Glomerular filtration rate and parathyroid-hormone secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 2000; 94: 4458-61.